RNA interference-mediated gene silencing of cyclophilin A enhances the radiosensitivity of PAa human lung adenocarcinoma cells in vitro

Jiang,Xin; Zhang,Qiao‑Li; Tian,Ye‑Hong; Huang,Jin‑Chang; Ma,Guo‑Lin

doi:10.3892/ol.2017.5667

RNA interference-mediated gene silencing of cyclophilin A enhances the radiosensitivity of PAa human lung adenocarcinoma cells in vitro

Authors:
- Xin Jiang
- Qiao‑Li Zhang
- Ye‑Hong Tian
- Jin‑Chang Huang
- Guo‑Lin Ma
View Affiliations

Affiliations: Graduate School, Beijing University of Chinese Medicine, Beijing 100029, P.R. China, Department of Acupuncture and Minimally Invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, P.R. China, Department of Gastroenterology, Xianyang Hospital of Yan'an University, Xianyang, Shanxi 712000, P.R. China, Department of Radiology, China‑Japan Friendship Hospital, Beijing 100029, P.R. China
Published online on: February 1, 2017 https://doi.org/10.3892/ol.2017.5667
Pages: 1619-1624
Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radiotherapy is currently the major therapeutic strategy for patients with lung cancer. However, radioresistance and various side effects continue to present challenging issues for this form of treatment. A recent study demonstrated that cyclophilin A (CyPA) was overexpressed in non‑small cell lung cancer and, therefore, presents a novel potential therapeutic target. In addition, gene‑radiotherapy is a novel method for cancer treatment. Therefore, the objective of the present study was to investigate the potential effect of CyPA silencing on radiosensitivity in human lung adenocarcinoma in vitro. The stable CyPA‑silencing lung adenocarcinoma (PAa) cell line was generated using lentivirus-mediated small hairpin RNAs. The knockdown of CyPA was determined using fluorescent microscopy and western blot analysis. Cells were irradiated using various doses of cobalt‑60 (0, 2, 4, 6 and 8 Gy). The radiosensitizing effects were determined by a clonogenic survival assay. Apoptosis and cell cycle distribution were evaluated using flow cytometry. Silencing of CyPA significantly increased the apoptosis of PAa cells. In addition, the radiosensitivity of cells was markedly enhanced following CyPA silencing. Furthermore, silencing of CyPA, in combination with irradiation, induced G2/M phase cell cycle arrest. Taken together, the data suggest that the silencing of CyPA, combined with radiation therapy, may increase the therapeutic efficacy of lung cancer treatment through regulation of the cell cycle and apoptosis‑associated signaling pathways.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Center MM, DeSantis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010. View Article : Google Scholar : PubMed/NCBI
3	Houston KA, Henley SJ, Li J, White MC and Richards TB: Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer. 86:22–28. 2014. View Article : Google Scholar : PubMed/NCBI
4	Baker S, Dahele M, Lagerwaard FJ and Senan S: A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol. 11:1152016. View Article : Google Scholar : PubMed/NCBI
5	Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, Gibson M, Epperly M and Levina V: Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer. 12:942013. View Article : Google Scholar : PubMed/NCBI
6	Ma W, Ma CN, Li XD and Zhang YJ: Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancer. Cancer Gene Ther. 23:66–71. 2016. View Article : Google Scholar : PubMed/NCBI
7	Torres-Roca JF and Stevens CW: Predicting response to clinical radiotherapy: Past, present, and future directions. Cancer Control. 15:151–156. 2008.PubMed/NCBI
8	Thapar R: Roles of Prolyl Isomerases in RNA-mediated gene expression. Biomolecules. 5:974–999. 2015. View Article : Google Scholar : PubMed/NCBI
9	Nigro P, Pompilio G and Capogrossi MC: Cyclophilin A: A key player for human disease. Cell Death Dis. 4:e8882013. View Article : Google Scholar : PubMed/NCBI
10	Feng W, Xin Y, Xiao Y, Li W and Sun D: Cyclophilin A enhances cell proliferation and xenografted tumor growth of early gastric cancer. Dig Dis Sci. 60:2700–2711. 2015. View Article : Google Scholar : PubMed/NCBI
11	Campa MJ, Wang MZ, Howard B, Fitzgerald MC and Patz EJ Jr: Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res. 63:1652–1656. 2003.PubMed/NCBI
12	Qian Z, Zhao X, Jiang M, Jia W, Zhang C, Wang Y, Li B and Yue W: Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9. BMC Cancer. 12:4422012. View Article : Google Scholar : PubMed/NCBI
13	Howard BA, Furumai R, Campa MJ, Rabbani ZN, Vujaskovic Z, Wang XF and Patz EF Jr: Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res. 65:8853–8860. 2005. View Article : Google Scholar : PubMed/NCBI
14	Huang JC, Zhao PC, Zhang HZ and Wang H: A proteomical study on the radiosensitized target molecules of fuzheng zengxiao formula in pulmonary adenocarcinoma nude mice model. J Tradit Chin Med. 31:3–6. 2011. View Article : Google Scholar : PubMed/NCBI
15	Zhang S, Joseph G, Pollok K, Berthoux L, Sastry L, Luban J and Cornetta K: G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer. Mol Ther. 14:546–554. 2006. View Article : Google Scholar : PubMed/NCBI
16	Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D and Naldini L: A third-generation lentivirus vector with a conditional packaging system. J Virol. 72:8463–8471. 1998.PubMed/NCBI
17	Sampsonas F, Ryan D, McPhillips D and Breen DP: Molecular testing and personalized treatment of lung cancer. Curr Mol Pharmacol. 7:22–32. 2014. View Article : Google Scholar : PubMed/NCBI
18	Brazin KN, Mallis RJ, Fulton DB and Andreotti AH: Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci USA. 99:1899–1904. 2002. View Article : Google Scholar : PubMed/NCBI
19	Choi KJ, Piao YJ, Lim MJ, Kim JH, Ha J, Choe W and Kim SS: Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia-and cisplatin-induced cell death. Cancer Res. 67:3654–3662. 2007. View Article : Google Scholar : PubMed/NCBI
20	Li Y, Guo H, Dong D, Wu H and Li E: Expression and prognostic relevance of cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma. Diagn Pathol. 8:2072013. View Article : Google Scholar : PubMed/NCBI
21	Obchoei S, Weakley SM, Wongkham S, Wongkham C, Sawanyawisuth K, Yao Q and Chen C: Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Mol Cancer. 10:1022011. View Article : Google Scholar : PubMed/NCBI
22	Kaliberov SA, Kaliberova LN, Yan H, Kapoor V and Hallahan DE: Retargeted adenoviruses for radiation-guided gene delivery. Cancer Gene Ther. 23:303–314. 2016. View Article : Google Scholar : PubMed/NCBI
23	Zhuang HQ, Sun J, Yuan ZY, Wang J, Zhao LJ, Wang P, Ren XB and Wang CL: Radiosensitizing effects of gefitinib at different administration times in vitro. Cancer Sci. 100:1520–1525. 2009. View Article : Google Scholar : PubMed/NCBI
24	Björk-Eriksson T, West C, Karlsson E and Mercke C: Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int J Radiat Oncol Biol Phys. 46:13–19. 2000. View Article : Google Scholar : PubMed/NCBI
25	Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
26	Wang T, Carraway RE, LaRoche D and FitzGerald TJ: Disruption of ERK1/2 Sensitizes radiation resistance prostate cancer cells to paclitaxel and ionizing radiation. Int J Radiat Oncol Biol Phys. 90:(Suppl). S8062014. View Article : Google Scholar